US fairness opinion providers
Q2 2026 · Fairness opinions on deals announced · 54 deals · US$266bn disclosed
Columns
Every deal that counts towards this table, with the firms credited on it. Tick deals to leave them out of the ranking or to rank only those deals; the page then says the ranking is a custom view.
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2026 | Iridium Communications | – | Rocket Lab | Acquisition | 7,589.9 | Announced | Telecom+1 | Evercore (sell-side) | Rocket Lab acquisition of Iridium Communications | |
| Jun 2026 | Theravance Biopharma | – | Zymeworks | Acquisition | 929.0 | Pending | Pharma+1 | Lazard (sell-side) | Zymeworks acquisition of Theravance Biopharma | |
| Jun 2026 | Bio-Techne | – | Merck KGaA | Acquisition | 11,300.0 | Pending | Life Sciences+1 | Goldman Sachs (sell-side) | Merck KGaA acquisition of Bio-Techne | |
| Jun 2026 | Keweenaw Financial Corp. | – | – | Merger | – | Announced | Banking+1 | Performance Trust Capital Partners (sell-side)Piper Sandler (buy-side) | Range Financial Corp. and Keweenaw Financial Corp. merger | |
| Jun 2026 | Identiv IoT business | Identiv | Trackonomy | Asset sale | 50.0 | Completed | Hardware & Semiconductors | Raymond James (sell-side) | Trackonomy acquisition of Identiv IoT business | |
| Jun 2026 | Fortitude Mining HoldCo | Fortitude Mining Holdings | HeartSciences | Merger | 18.2 | Announced | Crypto & Web3 | Houlihan Capital (buy-side) | HeartSciences and Fortitude Mining HoldCo merger | |
| Jun 2026 | Apogee Therapeutics | – | AbbVie | Acquisition | 10,900.0 | Pending | Biotech+2 | Goldman Sachs (sell-side)Jefferies (sell-side) | AbbVie acquisition of Apogee Therapeutics | |
| Jun 2026 | Arcosa | – | CRH | Acquisition | 8,500.0 | Announced | Building Materials+2 | Evercore (sell-side)Goldman Sachs (sell-side) | CRH acquisition of Arcosa | |
| Jun 2026 | AstroNova | – | Arcline Investment Management | Acquisition | – | Completed | Manufacturing+2 | Rockefeller Financial (sell-side) | Arcline Investment Management acquisition of AstroNova | |
| Jun 2026 | Simulations Plus | – | Affiliates of Altaris | Acquisition | 375.0 | Announced | Life Sciences+2 | Morgan Stanley (sell-side) | Affiliates of Altaris acquisition of Simulations Plus | |
| Jun 2026 | Open Lending | – | ANV Group Holdings | Acquisition | – | Completed | Insurtech+1 | Financial Technology Partners (sell-side) | ANV Group Holdings acquisition of Open Lending | |
| Jun 2026 | Huntsman | – | – | Merger | 2,117.0 | Pending | Chemicals | Lazard (buy-side)Citi (sell-side)Morgan Stanley (sell-side) | Olin and Huntsman merger | |
| Jun 2026 | Roku | – | Fox | Acquisition | 24,659.0 | Announced | Media & Entertainment+2 | Qatalyst Partners (sell-side)Allen & Company (buy-side) | Fox acquisition of Roku | |
| Jun 2026 | Payoneer Global | – | Nuvei | Acquisition | 2,750.0 | Announced | Payments | Qatalyst Partners (sell-side) | Nuvei acquisition of Payoneer Global | |
| Jun 2026 | National Capital Bancorp | – | – | Merger | – | Announced | Banking+1 | Piper Sandler (sell-side)D.A. Davidson (buy-side) | ODNB Financial and National Capital Bancorp merger | |
| Jun 2026 | Nuvalent | – | GSK | Acquisition | 10,600.0 | Pending | Biotech+2 | Centerview Partners (sell-side) | GSK acquisition of Nuvalent | |
| Jun 2026 | NCS Multistage Holdings | – | Weatherford International | Acquisition | – | Announced | Energy Services+1 | Piper Sandler (sell-side) | Weatherford International acquisition of NCS Multistage Holdings | |
| May 2026 | Taylor Morrison Home | – | Berkshire Hathaway | Acquisition | 8,500.0 | Completed | Home Building+1 | Goldman Sachs (sell-side)Moelis & Company (sell-side) | Berkshire Hathaway acquisition of Taylor Morrison Home | |
| May 2026 | Caesars Entertainment | – | Fertitta Entertainment | Acquisition | 17,600.0 | Announced | Gambling | PJT Partners (sell-side) | Fertitta Entertainment acquisition of Caesars Entertainment | |
| May 2026 | AvalonBay Communities | – | – | Merger | 24,709.8 | Completed | REITs | Goldman Sachs (buy-side)Morgan Stanley (buy-side) | Equity Residential and AvalonBay Communities merger | |
| May 2026 | Dominion Energy | – | NextEra Energy | Merger | 62,387.0 | Announced | Utilities+1 | Goldman Sachs (sell-side)J.P. Morgan (sell-side)Lazard (buy-side)BofA Securities (buy-side) | NextEra Energy and Dominion Energy merger | |
| May 2026 | Orphai Therapeutics | – | Quince Therapeutics | Acquisition | – | Completed | Biotech+2 | Oppenheimer & Co. (buy-side) | Quince Therapeutics acquisition of Orphai Therapeutics | |
| May 2026 | LiveRamp | – | Publicis Groupe | Acquisition | 2,600.0 | Announced | Software+2 | Evercore (sell-side) | Publicis Groupe acquisition of LiveRamp | |
| May 2026 | NSTS Bancorp | – | Brookfield Bancshares | Merger | 73.7 | Announced | Banking+1 | Olsen Palmer (sell-side) | Brookfield Bancshares and NSTS Bancorp merger | |
| May 2026 | Archenia | Russell C. Horowitz | Marchex | Acquisition | 10.0 | Announced | Software+1 | Craig-Hallum (buy-side) | Marchex acquisition of Archenia | |
| May 2026 | Emerald Holding | Onex Partners | Apollo Funds | Acquisition | 1,500.0 | Completed | Events and trade shows+1 | Goldman Sachs (sell-side) | Apollo Funds acquisition of Emerald Holding | |
| May 2026 | Catalyst Pharmaceuticals | – | Angelini Pharma S.p.A. | Acquisition | 4,100.0 | Pending | Pharma+1 | J.P. Morgan (sell-side) | Angelini Pharma S.p.A. acquisition of Catalyst Pharmaceuticals | |
| May 2026 | Mayville Financial Corp. | – | Tri-County Bancorp | Merger | – | Completed | Banking | Donnelly Penman & Partners (sell-side)Performance Trust Capital Partners (buy-side) | Tri-County Bancorp and Mayville Financial Corp. merger | |
| May 2026 | Cross Country Healthcare | – | Knox Lane | Acquisition | 437.0 | Completed | Healthcare Staffing | BofA Securities (sell-side) | Knox Lane acquisition of Cross Country Healthcare | |
| May 2026 | First Seacoast Bancorp | – | Cambridge Financial Group | Merger | 81.0 | Announced | Banking+1 | Keefe, Bruyette & Woods (sell-side) | Cambridge Financial Group and First Seacoast Bancorp merger | |
| May 2026 | Modiv Industrial | – | Global Net Lease | Acquisition | 535.0 | Completed | REITs | Truist Securities (sell-side) | Global Net Lease acquisition of Modiv Industrial | |
| May 2026 | Global Business Travel Group | – | Long Lake Management | Acquisition | 6,300.0 | Completed | Travel+2 | Rothschild & Co (sell-side) | Long Lake Management acquisition of Global Business Travel Group | |
| May 2026 | Esperion Therapeutics | – | ARCHIMED | Acquisition | 1,100.0 | Pending | Pharma+1 | Centerview Partners (sell-side) | ARCHIMED acquisition of Esperion Therapeutics | |
| Apr 2026 | KalVista Pharmaceuticals | – | Chiesi Group | Acquisition | 1,900.0 | Completed | Pharma+2 | Centerview Partners (sell-side) | Chiesi Group acquisition of KalVista Pharmaceuticals | |
| Apr 2026 | Aterian marquee brand portfolio | Aterian | Trademark Global | Asset sale | 18.0 | Pending | Consumer Brands+1 | A.G.P./Alliance Global Partners (sell-side) | Trademark Global acquisition of Aterian marquee brand portfolio | |
| Apr 2026 | XOMA Royalty | – | Ligand Pharmaceuticals | Acquisition | 739.0 | Completed | Specialty finance and leasing+2 | Leerink Partners (sell-side) | Ligand Pharmaceuticals acquisition of XOMA Royalty | |
| Apr 2026 | RE/MAX Holdings | – | The Real Brokerage | Merger | 330.9 | Pending | Real Estate+2 | J.P. Morgan (sell-side)Morgan Stanley (buy-side) | The Real Brokerage and RE/MAX Holdings merger | |
| Apr 2026 | Organon & Co. | – | Sun Pharmaceutical Industries | Acquisition | 11,750.0 | Announced | Pharma | Morgan Stanley (sell-side) | Sun Pharmaceutical Industries acquisition of Organon & Co. | |
| Apr 2026 | TruBridge | – | Inventurus Knowledge Solutions | Acquisition | – | Announced | Healthcare Software+1 | Solomon Partners (sell-side) | Inventurus Knowledge Solutions acquisition of TruBridge | |
| Apr 2026 | Kashiv BioSciences | – | Amneal Pharmaceuticals | Acquisition | 375.0 | Completed | Biotech+2 | Goldman Sachs (buy-side) | Amneal Pharmaceuticals acquisition of Kashiv BioSciences | |
| Apr 2026 | Cumberland FDA-approved commercial products and related assets | Cumberland Pharmaceuticals | Nuvo Pharmaceuticals (Ireland) DAC | Asset sale | 100.0 | Pending | Pharma | VelocityHealth Securities (sell-side) | Nuvo Pharmaceuticals (Ireland) DAC acquisition of Cumberland FDA-approved commercial products and related assets | |
| Apr 2026 | Citizens National | – | Peoples Bancorp | Merger | 76.6 | Announced | Banking | Hovde Group (sell-side) | Peoples Bancorp and Citizens National merger | |
| Apr 2026 | LivePerson | – | SoundHound AI | Acquisition | 42.8 | Pending | Software+2 | Houlihan Lokey (sell-side) | SoundHound AI acquisition of LivePerson | |
| Apr 2026 | Electro-Sensors | – | steute Technologies GmbH & Co. KG | Acquisition | – | Pending | Instrumentation+1 | Lake Street Capital Markets (sell-side) | steute Technologies GmbH & Co. KG acquisition of Electro-Sensors | |
| Apr 2026 | Sila Realty Trust | – | Blue Owl Real Estate Capital LLC affiliates | Acquisition | 2,400.0 | Completed | REITs+1 | BofA Securities (sell-side) | Blue Owl Real Estate Capital LLC affiliates acquisition of Sila Realty Trust | |
| Apr 2026 | TopBuild Corp. | – | QXO | Acquisition | 17,000.0 | Completed | Distribution+1 | Goldman Sachs (sell-side)RBC Capital Markets (sell-side)Morgan Stanley (buy-side) | QXO acquisition of TopBuild Corp. | |
| Apr 2026 | Sweetwater Royalties | Orion Resource Partners LP | Uranium Royalty Corp. | Acquisition | 1,900.0 | Announced | Mineral and royalty interests+2 | Paradigm Capital (buy-side) | Uranium Royalty Corp. acquisition of Sweetwater Royalties | |
| Apr 2026 | Avanos Medical | – | AIP | Acquisition | 1,272.0 | Completed | Medtech | J.P. Morgan (sell-side) | AIP acquisition of Avanos Medical | |
| Apr 2026 | Globalstar | – | Amazon | Acquisition | 11,400.0 | Announced | Telecom | Evercore (sell-side) | Amazon acquisition of Globalstar | |
| Apr 2026 | Obsidian Therapeutics | – | Galera Therapeutics | Merger | 413.5 | Completed | Biotech+2 | Lucid Capital Markets (buy-side) | Galera Therapeutics and Obsidian Therapeutics merger | |
| Apr 2026 | Leggett & Platt | – | Somnigroup International | Acquisition | 2,300.0 | Completed | Manufacturing+1 | J.P. Morgan (sell-side) | Somnigroup International acquisition of Leggett & Platt | |
| Apr 2026 | Whitestone REIT | – | MCB Real Estate | Acquisition | 1,700.0 | Completed | REITs | BofA Securities (sell-side) | MCB Real Estate acquisition of Whitestone REIT | |
| Apr 2026 | Soleno Therapeutics | – | Neurocrine Biosciences | Acquisition | 2,900.0 | Completed | Biotech+2 | Centerview Partners (sell-side)Guggenheim Securities (sell-side) | Neurocrine Biosciences acquisition of Soleno Therapeutics | |
| Apr 2026 | Forian | – | Max Wygod | Acquisition | 68.0 | Announced | Healthcare Software+1 | Houlihan Lokey (sell-side) | Max Wygod acquisition of Forian |
9 deals have no disclosed value. Q2 2025 rank is the firm's place in the same period a year earlier, under the same filters. Methodology